跳至主要内容
临床试验/CTRI/2023/12/060444
CTRI/2023/12/060444招募中2 期

A randomized, double-blind, placebo-controlled pilot study to evaluate the effect of centhaquine on cardiovascular parameters in patients with hypovolemic shock. - NI

Aman Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult males or females aged 18 years or older.
  • Subjects with hypovolemic shock admitted to the hospital with systolic
  • blood pressure = 90 mmHg at presentation and continue to receive
  • standard treatment of shock (endotracheal intubation; fluid resuscitation,
  • and vasopressors). The best available standard of care to be provided to the
  • Blood lactate level indicative of hypovolemic shock with lactate level more
  • than 2 mmol/L.
  • Informed consent provided by the patient or legally authorised
  • representative of the patient

排除标准

  • 1. Subject with illness clinically defined as septic shock (confirmed or
  • suspected acute infection), cardiogenic shock, neurogenic shock.
  • 2.Subject for whom an etiology for hypovolemic shock cannot be determined
  • on initial evaluation.
  • 3. Hypovolemic shock due to traumatic brain injury including any significant
  • CNS injury, traumatic tamponade, traumatic tension pneumothorax, ventricular wall rupture.
  • 4. Patient with altered consciousness not due to hypovolemic shock.
  • 5. Subject with confirmed pregnancy.
  • 6. Cardiopulmonary resuscitation (CPR) before randomization.
  • 7. Presence of a do not resuscitate order.
  • 8. Patient is participating in another interventional study.
  • 9. Patients with a history of systemic disease (chronic renal failure, liver failure, decompensated heart failure) or any terminal illness.

研究者

发起方
Aman Hospital and Research Centre

相似试验